“More than VEGF A -“
Dual pathway inhibitor of Ang-2 & VEGF-A, new era in retinal vascular disease management on 25/11/22 at the Westin, Dhaka
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF1-1-1024x768.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF1-1-1024x768.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF2-1.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF2-1.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF3-1.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF3-1.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF4-1.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF4-1.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF5-2.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF5-2.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF6-1.jpg)
![](https://www.bvrs.org.bd/wp-content/uploads/2022/11/VEGF6-1.jpg)